Emerging Trends to Reshape the Veterinary Biologics Market: Merck Animal Health Launches USDA-Approved Vaccine For Avian Metapneumovirus To Address Poultry Respiratory Issues as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Veterinary Biologics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for veterinary biologics has seen robust growth in the past few years. It's projected to rise from $12.67 billion in 2024 to reach $13.61 billion in 2025, marking a compound annual growth rate (CAGR) of 7.4%. Several factors have contributed to this growth during the historic period, including outbreaks of animal diseases, established regulatory support and standards, the need for safe food, globalization of trade, and the economic importance of livestock.

Veterinary Biologics Market Size Forecast: What's the Projected Valuation by 2029?
Expectations are high for the veterinary biologics market to experience significant growth in the coming years, escalating to a sizeable $18.36 billion by 2029. This showcases a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this predicted rise during the forecast period include the appearance of new infectious diseases, shifts in disease patterns due to climate change, precision in livestock farming, a collective approach to health, and a surge in pet ownership trends. Other key trends during the future period include investments in education and training programs, development of eco-friendly and sustainable biologics, digital health record integration, growth in companion animal biologics, and the provision of customized and targeted therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

What Are the Drivers Transforming the Veterinary Biologics Market?
Increased instances of illnesses in animals are predicted to boost the veterinary biologics market's expansion. Animal diseases encompass various health concerns afflicting different species of animals. The rise in animal disease warrants the need for improved diagnosis and treatment solutions, which can be provided using veterinary biologics that employ immunological techniques to combat these diseases. As an illustration, the European Centre for Disease Prevention and Control reported in October 2022 a total of 2,467 outbreaks of avian influenza in poultry in Sweden, impacting 48 million birds, and 187 cases were found in captive birds. Moreover, in July 2022, the World Health Organization reported that rabies results in the death of about 59,000 people yearly across more than 150 countries, with Africa and Asia accounting for 95% of these instances. Consequently, the escalating scenarios of animal diseases are catalyzing the demand for veterinary biologics.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

What Long-Term Trends Will Define the Future of the Veterinary Biologics Market?
Leading businesses in the veterinary biologics field are concentrating on creating innovative biologics such as vaccines to improve animal health and reduce illnesses. By inducing acquired immunity, vaccines train the immune system to detect and combat specific pathogens, helping to avoid infectious illnesses. For example, Merck Animal Health, an international animal health firm based in the US, introduced an experimental self-developed vaccine for avian metapneumovirus (aMPV) type B in August 2024. With approval from the U.S. Department of Agriculture (USDA), the vaccine was developed in partnership with Cambridge Technologies to address the severe respiratory problems caused by aMPV type B in poultry, which resulted in substantial economic damage starting in late 2023. The vaccine, which was made in a high-tech facility in Minnesota, uses an oil-water emulsion formulation to decrease tissue reactions post-vaccination. This filled a crucial void in the market since there were no commercially licensed vaccines available before.

Which Segments in the Veterinary Biologics Market Offer the Most Profit Potential?
The veterinary biologics market covered in this report is segmented -

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal

Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Which Firms Dominate the Veterinary Biologics Market by Market Share and Revenue in 2025?
Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

Which Regions Offer the Highest Growth Potential in the Veterinary Biologics Market?
North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.